Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FACT complex subunit SPT16 (SUPT16H) is the large subunit of the FACT (Facilitates Chromatin Transcription) complex, an evolutionarily conserved histone chaperone involved in reorganizing nucleosomes to permit access for transcription, DNA replication, and DNA repair machinery[1][2][3]. SUPT16H binds to histones H2A/H2B and H3/H4, mediating nucleosome disassembly during RNA polymerase II transcription elongation and then restoring chromatin structure post-transcription[1][2][3]. Loss-of-function variants in SUPT16H are associated with severe developmental disorders, including neurodevelopmental delay, intellectual disability, and epilepsy[3]. The gene is expressed ubiquitously and is essential for cell growth and survival[3]. No clinically approved drugs specifically target SUPT16H, and it is not currently known to be used as a biomarker or for therapeutic targeting, though its pivotal cellular functions make it an emerging point of interest in chromatin regulation research[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FACT complex subunit SPT16 (SUPT16H).